Genomic Damage in Endstage Renal Disease—Contribution of Uremic Toxins

Patients with end-stage renal disease (ESRD), whether on conservative, peritoneal or hemodialysis therapy, have elevated genomic damage in peripheral blood lymphocytes and an increased cancer incidence, especially of the kidney. The damage is possibly due to accumulation of uremic toxins like advanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Schupp, Nicole, Heidland, August, Stopper, Helga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153169/
https://www.ncbi.nlm.nih.gov/pubmed/22069557
http://dx.doi.org/10.3390/toxins2102340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153169/
https://www.ncbi.nlm.nih.gov/pubmed/22069557
http://dx.doi.org/10.3390/toxins2102340

Ejemplares similares